Lv1
40 积分 2026-08-30 加入
Challenges and advances in CAR-T cell therapy for B-ALL
20小时前
待确认
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia
1个月前
已完结
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
1个月前
已完结
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
1个月前
已完结
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
1个月前
已完结
Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
1个月前
已完结
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia
1个月前
已完结
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission
1个月前
已完结
Targeting the brain after spinal cord injury: Targeted deep brain stimulation improves walking after injury
1个月前
已完结
皖公网安备34019202002308
